GCIHybridan Small Cap Feast: 24/07/24
* A corporate client of Hybridan LLP
** Arranged by type of listing and date of announcement
*** Alphabetically arranged
**** Potential means Intention to Float (ITF) has been announced, or it is a rumour
Dish of the day
Admissions:
formerly Pathfinder Minerals Plc has relisted on the AIM market following its reverse takeover.
What’s baking in the oven? **
Banquet Buffet***
The diversified UK leisure and entertainment business provides the following trading update for the first half of its financial year period ended 23 June 2024. As previously announced, the first 18 weeks of the year saw like-for-like sales approximately £0.5m below the equivalent period in 2023, owing primarily to poor weather impacting trading on Brighton Palace Pier. Poor weather has continued adversely impacting sales at the Pier, through a combination of rides closures and lower footfall. Entering into the busy July summer holiday season, footfall for the 4 week July period (ending on 21 July) was down 29% compared to the equivalent weeks in 2023. The Group has yet to trade the remaining six weeks of the summer season through to the end of August. This period has typically contributed a significant portion of annual Group sales and earnings. However, despite the earnings from admission revenue, and the potential for improved weather in August, the Group no longer believes the year to date sales and earnings shortfall will be recovered and accordingly expect the Group's EBITDA for the full financial year to be below market expectations.
The Company that develops and markets digital solutions to assess brain health announces that further to the announcement on 12 October 2022 regarding the acquisition of eClinicalHealth Limited (Clinpal), the Company has today issued new ordinary shares at an issue price of 132.97p to certain shareholders of Clinpal, representing approximately £0.3m of the contingent consideration. No further consideration is due to former shareholders of Clinpal.
The net zero energy services provider announces an update on trading for the six months ended 30 June 2024. Core revenue of £6.2m (pro forma H1 23: £11.0m), core adjusted EBITDA loss of £2.1m (pro forma H1 23: £0.5m) and £5.2m solar contract signed with Spire Healthcare plc, the Group's largest to date . Up to £40m project funding facility with National Westminster Bank Plc to finance energy efficiency and onsite generation technologies for the Group's public sector customers. H2 24 started with strong momentum, with positive signs of market recovery and has entered H2 24 with a robust contracted forward order book of which £12.9m is expected to convert to revenue in H2 24, comprising 75% of forecast H2 24 Solar revenues and 44% of forecast H2 24 LED revenues.
A technology innovator powering distributed, decarbonised, new energy infrastructure through its waste-to-value solutions for hydrogen, biofuels, and energy generation confirms the acquisition of two lots of property in Castiglione d'Orcia (SI), Italy that house the EQTEC Italia MDC plant and feedstock storage facilities. The Property includes land, buildings and associated rights of way. Formal completion of the Property acquisition occurred on 25 July 2024 and accordingly, EQTEC Italia MDC Srl's ownership of the Property is now registered with the Siena provincial authorities. The consideration for the Transaction was EUR 0.57m in cash, funded by Italia MDC from the EUR 2.9m facility provided by Banda del Fucino S.p.A. announced by the Company on 16 January 2024.
The miner and marketer of coloured gemstones has released information about its operational results and financial position for the six months ended 30 June 2024. Total auction revenues of $121m with continued demand for rough emeralds and rubies, net debt position of $44.4m (before auction receivables of $65.5m) at 30 June 2024, as Gemfields continues to invest in its previously communicated capital expenditure plan, funded through a mixture of cash reserves and increased debt. $10m was returned to shareholders in 2024 to reflect the good results in 2023.
The provider of creative and technology-enabled solutions to the video games and entertainment industries today provides a trading update in respect of 2024 performance. The Board remains confident in delivering good overall revenue growth in 2024, with performance expected to be second half weighted as the sector starts to emerge from the slower content creation trends that are currently dampening industry spend and therefore Keywords' growth. Keywords has had a small number of larger game development projects deferred or cancelled in H1, creating capacity gaps in Create which were unable to be filled at short notice. This, together with ongoing softer demand in Globalize and the relatively slow ramp-up in content production in Hollywood, has meant that reported revenue is expected to grow by around 7%. in the first half, with organic growth over the period expected to be around minus 2%. The Board continues to be confident in the Group's ability to outperform the market and deliver on its medium-term guidance beyond 2024.
The legal and professional services business announces that it has agreed to acquire Thursfields Legal Limited, a premium, full service legal services business with offices across the West Midlands. Knights will acquire Thursfields Legal Limited from its ten shareholders on a debt free, cash free basis, for a total consideration of c.£12.5m. This comprises initial cash consideration of c.£7.5m and deferred cash consideration of £5.0m to be paid in three equal instalments on each of the first, second and third anniversaries following completion. The cash consideration will be satisfied from Knights' existing banking facilities. Completion is expected to take place on 14 September 2024.
The oil and gas company with a 100% working interest in the Kodiak and Ahpun projects located in close proximity to pipeline and transportation infrastructure on Alaska's North Slope today announces the results of the Fundraise and Retail Offer which was announced yesterday. The Fundraise was heavily oversubscribed and the Company, having taken into account the strong support received from existing and new investors, decided to increase the size of the Fundraise, and when combined with the Retail Offer, raised gross proceeds of approximately $29m before costs. Placing, Subscription and Retail Offer at a price of 17p which is a 14% discount to close price on 24 July 2024. The additional funds raised in the Fundraise will be applied towards data acquisition such as collecting whole core, tests of multiple horizons and, in a success case, a possible long term production test at Megrez-1, as well as further development of the Company's asset portfolio and general corporate purposes.
A biopharmaceutical company focussed on the development and commercialisation of innovative medicines targeting diseases with a high unmet medical need announces that it is voluntarily delisting its ordinary shares from trading on the OTCQB Market due to low trading volume and the associated administrative requirements. The Company's last day of trading on the OTCQB Market will be Monday 29 July 2024. Poolbeg will retain its listing on the London Stock Exchange's AIM Market under its existing ticker POLB. The delisting from the OTCQB market will have no impact on Poolbeg's Ordinary Shares, which will continue to trade on the AIM Market. Poolbeg reaffirms its ambitions to be dual listed on a national securities exchange in the US, such as Nasdaq, subject to meeting their listing requirements at the appropriate time.
An exploration-stage company. Its principal business is the exploration and evaluation of assets in southern Africa to identify and develop CBM (Coal Bed Methane) resources provides an update for the quarter ended 30 June 2024. At the end of the quarter the Company had A$2.52m cash on hand (unaudited). The aggregate value of payments to related parties and their associates of A$340k for the quarter relates to directors' salaries and fees (including tax and superannuation payments made on their behalf) and office rent. Lesedi electrical substation is 64% complete with expected completion in 3Q 2024, Lesedi remains at the forefront of Botswana's gas to power sector, making substantial progress in the development of the proposed 10MW gas-to-power project.
This document has been issued to you by Hybridan LLP for information purposes only and should not be construed in any circumstances as an offer to sell or solicitation of any offer to buy any security or other financial instrument, nor shall it, or the fact of its distribution, form the basis of, or be relied upon in connection with, any contract relating to such action. This document has no regard for the specific investment objectives, financial situation or needs of any specific entity and is not a personal recommendation to anyone. Recipients should make their own investment decisions based upon their own financial objectives and financial resources and, if any doubt, should seek advice from an investment advisor.
The information contained in this document is based on materials and sources that are believed to be reliable; however, they have not been independently verified and are not guaranteed as being accurate. This document is not intended to be a complete statement or summary of any securities, markets, reports or developments referred to herein. No representation or warranty, either express or implied, is made or accepted by Hybridan LLP, its members, directors, officers, employees, agents or associated undertakings in relation to the accuracy, completeness or reliability of the information in this document nor should it be relied upon as such.
Any and all opinions expressed are current opinions as of the date appearing on this document only. Any and all opinions expressed are subject to change without notice and Hybridan LLP is under no obligation to update the information contained herein. To the fullest extent permitted by law, none of Hybridan LLP, its members, directors, officers, employees, agents or associated undertakings shall have any liability whatsoever for any direct or indirect or consequential loss or damage (including lost profits) arising in any way from use of all or any part of the information in this document.
This document is sent to you as market commentary only. As market commentary this document does not constitute any of (i) investment research and financial analysis or other forms of general recommendation relating to transactions in financial instruments for the purposes of the UK retained version of section B of annex I to Directive 2014/65/EU ("MIFID II Directive"); or (ii) investment research as defined in the UK retained version of article 36(1) of Commission Delegated Regulation 2017/565/EU made pursuant to the MIFID II Directive; or (iii) non-independent research (as such term is defined in the Financial Conduct Authority's Conduct of Business Sourcebook).
This document should not be relied upon as being an independent or impartial view of the subject matter. The individuals who prepared this document may be involved in providing other financial services to the company or companies referenced in this document or to other companies who might be said to be competitors of the company or companies referenced in this document. As a result both Hybridan LLP and the individual members, officers and/or employees who prepared this document may have responsibilities that conflict with the interests of the persons who receive this document. Hybridan LLP and/or connected persons may, from time to time, have positions in, make a market in and/or effect transactions in any investment or related investment mentioned herein and may provide financial services to the issuers of such investments.
In the United Kingdom, this document is directed at and is for distribution only to persons who (i) fall within article 19(5) (persons who have professional experience in matters relating to investments) or article 49(2) (a) to (d) (high net worth companies, unincorporated associations, etc.) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (SI 2005/1529) (as amended) or (ii) persons who are each a professional client or eligible counterparty (as those terms are defined in the Financial Conduct Authority's Conduct of Business Sourcebook) of Hybridan LLP (all such persons referred to in (i) and (ii) together being referred to as "relevant persons"). This document must not be acted on or relied up on by persons who are not relevant persons. For the purposes of clarity, this document is not intended for and should not be relied upon by any person who would be classified as a retail client under the Financial Conduct Authority's Conduct of Business Sourcebook.
Neither this document nor any copy of part thereof may be distributed in any other jurisdictions where its distribution may be restricted by law and persons into whose possession this document comes should inform themselves about, and observe, any such restrictions. Distribution of this report in any such other jurisdictions may constitute a violation of territorial and/or extra-territorial securities laws, whether in the United Kingdom, the United States or any other jurisdiction in any part of the world.
Hybridan LLP and/or its associated undertakings may from time-to-time provide investment advice or other services to, or solicit such business from, any of the companies referred to in this document. Accordingly, information may be available to Hybridan LLP that is not reflected in this material and Hybridan LLP may have acted upon or used the information prior to or immediately following its publication. In addition, Hybridan LLP, the members, officers and/or employees thereof and/or any connected persons may have an interest in the securities, warrants, futures, options, derivatives or other financial instrument of any of the companies referred to in this document and may from time-to-time add or dispose of such interests.
This document may not be copied, redistributed, resent, forwarded, disclosed or duplicated in any form or by any means, whether in whole or in part other than with the prior written consent of Hybridan LLP.
Hybridan LLP is a limited liability partnership registered in England and Wales, registered number OC325178, and is authorised and regulated by the Financial Conduct Authority and is a member of the London Stock Exchange. Any reference to a partner in relation to Hybridan LLP is to a member of Hybridan LLP or an employee with equivalent standing and qualifications. A list of the members of Hybridan LLP is available for inspection at the registered office, 2 Jardine House, The Harrovian Business Village, Bessborough Road, Harrow, Middlesex HA1 3EX.
Disclaimer & Declaration of Interest
The information, investment views and recommendations in this article are provided for general information purposes only. Nothing in this article should be construed as a solicitation to buy or sell any financial product relating to any companies under discussion or to engage in or refrain from doing so or engaging in any other transaction. Any opinions or comments are made to the best of the knowledge and belief of the writer but no responsibility is accepted for actions based on such opinions or comments. Vox Markets may receive payment from companies mentioned for enhanced profiling or publication presence. The writer may or may not hold investments in the companies under discussion.